ARTICLE
10 December 2015

FDA Issues Guidance Titled "Over-The-Counter Sunscreens: Safety And Effectiveness Data"

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
As discussed above, in the November 23, 2015, Federal Register, FDA announced the availability of a draft guidance for industry titled "Over-the-Counter Sunscreens: Safety and Effectiveness Data."
United States Food, Drugs, Healthcare, Life Sciences

As discussed above, in the November 23, 2015, Federal Register, FDA announced the availability of a draft guidance for industry titled "Over-the-Counter Sunscreens: Safety and Effectiveness Data." This draft guidance addresses FDA's current thinking about the safety and effectiveness data needed to determine whether a nonprescription sunscreen active ingredient or combination of active ingredients evaluated under the SIA is GRASE and not misbranded when used under specified conditions. The guidance also addresses FDA's current thinking about an approach to safety-related final formulation testing that it anticipates adopting in the future. Comments are due January 22, 2016.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More